Can amoxicillin (Amoxil) cause a vaginal yeast infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Amoxicillin Cause Vaginal Yeast Infections?

Yes, amoxicillin directly causes vaginal yeast infections (vulvovaginal candidiasis) by disrupting the normal vaginal microbiome, and this is one of the most common and predictable adverse effects of antibacterial therapy. 1

Mechanism and Evidence

  • The FDA drug label for amoxicillin explicitly lists "mucocutaneous candidiasis" as an adverse reaction under infections and infestations. 1

  • Antibacterial therapy—whether systemic or locally applied—represents the single most frequent and predictable triggering mechanism of symptomatic vulvovaginal candidiasis, precipitating both sporadic and recurrent episodes. 2

  • The CDC recognizes that vulvovaginal candidiasis "can occur concomitantly with STDs or frequently following antibacterial vaginal or systemic therapy." 3

  • Antibiotics disrupt the protective vaginal lactobacillus flora, removing the natural restraints on yeast colonization and proliferation. 2 In one study of clarithromycin (a similar broad-spectrum antibiotic), lactobacillus presence dropped from 33% to 0% after treatment, while Candida incidence doubled from 17% to 33%. 4

Clinical Significance and Risk Factors

  • Approximately 75% of women will experience at least one episode of vulvovaginal candidiasis in their lifetime, and 40-45% will have two or more episodes. 3

  • Diabetes, any antibacterial treatment (including amoxicillin specifically), were statistically linked with vulvovaginal candidiasis in a large case series. 5

  • The predictable link between antibiotic use and post-antibiotic vulvovaginal candidiasis affords practitioners an opportunity for timely prophylactic intervention. 2

Prophylaxis and Management Strategy

For patients at high risk of recurrent candidiasis or with a history of post-antibiotic yeast infections, consider concurrent antifungal prophylaxis when prescribing amoxicillin:

  • Fluconazole 150 mg as a single oral dose at the start or completion of antibiotic therapy is the most convenient option. 6

  • Alternatively, topical azole therapy (clotrimazole 1% cream 5g intravaginally for 7-14 days, or miconazole 2% cream 5g intravaginally for 7 days) can be initiated if symptoms develop. 3, 6

  • Topical azoles achieve 80-90% symptom relief and negative cultures when used appropriately. 3

Key Clinical Pitfalls

  • Do not dismiss vaginal symptoms during or after amoxicillin therapy as unrelated; this is a direct, FDA-recognized adverse effect requiring treatment. 1

  • Avoid fluconazole in the first trimester of pregnancy due to associations with spontaneous abortion and congenital malformations; use topical azoles only during pregnancy. 7, 6

  • Counsel patients that approximately 10-20% of women normally harbor Candida in the vagina asymptomatically, so treatment should only occur when symptoms are present. 3, 6

  • Oil-based vaginal creams (butoconazole, clotrimazole, miconazole) weaken latex condoms and diaphragms; advise alternative contraception during treatment. 3, 7

References

Research

Vulvovaginitis Caused by Candida Species Following Antibiotic Exposure.

Current infectious disease reports, 2019

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clarithromycin-induced alterations in vaginal flora.

American journal of therapeutics, 2000

Guideline

Treatment of Vaginal Candida Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Co-Existing Vulvovaginal Candidiasis and Bacterial Vaginosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.